We are live on
!
Find out more
WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$4.16B
1-Year Est. Return
30.77%
This Fund
S&P 500
This Quarter
Est. Return
+3.17%
1 Year Est. Return
+30.77%
3 Year Est. Return
+78.91%
5 Year Est. Return
+263.81%
10 Year Est. Return
+424.97%
AUM
$2.25B
AUM Growth
-$652M
(-22%)
Cap. Flow
-$690M
Cap. Flow
% of AUM
-30.66%
Top 10 Holdings %
Top 10 Hldgs %
18.84%
Holding
596
New
201
Increased
82
Reduced
135
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SITE Centers
SITC
|
+$49.8M |
| 2 |
VR
Validus Hold Ltd
VR
|
+$36.1M |
| 3 |
Regions Financial
RF
|
+$26M |
| 4 |
SL Green Realty
SLG
|
+$25.5M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$24.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital One
COF
|
+$45.4M |
| 2 |
Truist Financial
TFC
|
+$33.1M |
| 3 |
KeyCorp
KEY
|
+$31.3M |
| 4 |
Intercontinental Exchange
ICE
|
+$27.4M |
| 5 |
Dollar General
DG
|
+$26.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 22.65% |
| 2 | Financials | 19.37% |
| 3 | Energy | 9.14% |
| 4 | Healthcare | 8.97% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
326
CALL
DELISTED
Esperion Therapeutics
ESPR
| $926K | 0.04% |
10,000
-50,000
| -83% | -$3.23M |
|
|
OCRX
327
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $918K | 0.04% |
195,000
-15,000
| -7% | -$86.5K |
|
|
CLLS
328
Cellectis
CLLS
$286M
| $909K | 0.04% |
+26,300
| New | +$954K |
|
|
GNMK
329
DELISTED
GenMark Diagnostics, Inc
GNMK
| $902K | 0.04% |
69,500
-5,500
| -7% | -$71.9K |
|
330
Oil States International
OIS
$524M
| $875K | 0.04% |
+22,000
| New | +$931K |
|
331
CALL
Pfizer
PFE
$140B
| $870K | 0.04% |
26,350
-28,985
| -52% | -$922K |
|
332
CALL
Golar LNG
GLNG
$4.95B
| $839K | 0.04% |
+25,200
| New | +$807K |
|
|
BCR
333
DELISTED
CR Bard Inc.
BCR
| $837K | 0.04% |
5,000
-5,000
| -50% | -$857K |
|
334
Rigel Pharmaceuticals
RIGL
$711M
| $821K | 0.04% |
23,000
+1,000
| +5% | +$27.4K |
|
335
PUT
DaVita
DVA
$15.2B
| $813K | 0.04% |
+10,000
| New | +$767K |
|
336
HealthEquity
HQY
$8.02B
| $812K | 0.04% |
+32,500
| New | +$705K |
|
337
Trupanion
TRUP
$1.08B
| $800K | 0.04% |
100,000
+17,500
| +21% | +$133K |
|
338
Ligand Pharmaceuticals
LGND
$6.08B
| $771K | 0.03% |
16,030
| – | – |
|
|
KTWO
339
DELISTED
K2M Group Holdings, Inc
KTWO
| $761K | 0.03% |
34,500
+9,500
| +38% | +$194K |
|
|
SAGE
340
DELISTED
Sage Therapeutics
SAGE
| $753K | 0.03% |
+15,000
| New | +$645K |
|
341
Acacia Research
ACTG
$456M
| $752K | 0.03% |
+70,300
| New | +$917K |
|
|
XLRN
342
DELISTED
Acceleron Pharma
XLRN
| $742K | 0.03% |
+19,500
| New | +$775K |
|
|
MZOR
343
DELISTED
Mazor Robotics Ltd.
MZOR
| $730K | 0.03% |
65,000
-5,000
| -7% | -$57.1K |
|
344
Expeditors International
EXPD
$22.6B
| $723K | 0.03% |
15,000
-54,000
| -78% | -$2.49M |
|
345
MPLX
MPLX
$59.2B
| $711K | 0.03% |
+9,700
| New | +$737K |
|
|
QGENF
346
DELISTED
QIAGEN NV
QGENF
| $701K | 0.03% |
27,800
-2,200
| -7% | -$55.5K |
|
347
PUT
Celldex Therapeutics
CLDX
$2.79B
| $697K | 0.03% |
+1,667
| New | +$596K |
|
348
Molina Healthcare
MOH
$10.3B
| $673K | 0.03% |
10,000
+5,000
| +100% | +$289K |
|
349
Pacific Biosciences
PACB
$429M
| $642K | 0.03% |
110,000
+2,700
| +3% | +$18.6K |
|
|
CPRX
350
DELISTED
Catalyst Pharmaceutical
CPRX
| $641K | 0.03% |
148,000
-12,000
| -8% | -$43.3K |
|
Similar funds
SS
PMEF
CC
GW
BC
GC
WP
BWM
Weiss Multi-Strategy Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, Weiss Multi-Strategy Advisers held 596 positions worth $2.25B, down 22% from $2.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Weiss Multi-Strategy Advisers withdrew a net $690M in Q1 2015, closing 168 positions and reducing 135 holdings. Its most notable exit was Capital One, an estimated $45.4M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 23% of assets, up from 14% a quarter earlier, followed by Financials and Energy.
Against the trend, Weiss Multi-Strategy Advisers opened a new position in SITE Centers worth $48.4M.
- Weiss Multi-Strategy Advisers's largest Q1 2015 buy was SITE Centers: 2,017,859 shares worth $48.4M.
- Weiss Multi-Strategy Advisers added most to Validus Hold Ltd in Q1 2015, an estimated $36.1M increase.
- Weiss Multi-Strategy Advisers's biggest Q1 2015 reduction was Arch Capital, cutting an estimated $24.8M.
- Weiss Multi-Strategy Advisers fully exited Capital One in Q1 2015, selling an estimated $45.4M.
- Weiss Multi-Strategy Advisers's ten largest holdings make up 19% of its $2.25B portfolio in Q1 2015.
- Weiss Multi-Strategy Advisers opened 201 new positions and closed 168 in Q1 2015.
- Weiss Multi-Strategy Advisers's portfolio value fell 22% quarter-over-quarter to $2.25B.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2015, filed 15 May 2015.